rts logo

Sonoma Pharmaceuticals Inc. (SNOA) – key numbers that make it a Strong Buy For Now

Sonoma Pharmaceuticals Inc. (NASDAQ: SNOA) is 10.31% higher on its value in year-to-date trading and has touched a low of $0.12 and a high of $1.52 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The SNOA stock was last observed hovering at around $0.23 in the last trading session, with the day’s loss setting it -0.03%.

Currently trading at $0.20, the stock is 19.27% and 25.83% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 4.71 million and changing -12.33% at the moment leaves the stock -44.69% off its SMA200. SNOA registered -79.05% loss for a year compared to 6-month loss of 24.84%.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

The stock witnessed a 26.43% gain in the last 1 month and extending the period to 3 months gives it a 28.89%, and is 31.35% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 38.36% over the week and 15.64% over the month.

Sonoma Pharmaceuticals Inc. (SNOA) has around 171 employees, a market worth around $3.11M and $12.31M in sales. Profit margin for the company is -41.23%. Distance from 52-week low is 71.70% and -86.91% from its 52-week high. The company has generated returns on investments over the last 12 months (-74.08%).

with sales reaching $3.98M over the same period., but quarterly earnings will post 10.40% year-over-year.

Sonoma Pharmaceuticals Inc. (SNOA) Top Institutional Holders

The shares outstanding are 15.61M, and float is at 15.38M with Short Float at 0.30%.

Related Posts